Hints and tips:
...“Nurtec checked five of six key criteria for Pfizer in picking an asset to acquire, including: high complement to the portfolio, high level of clinical de-risking, high commercial potential, low infrastructure...
...Sales of a third antiviral made by Japanese pharma company Shionogi are estimated at $0.5bn, down from $2.5bn, because of delays in the approval of the treatment....
...Losing the pharma licence might limit SpectrumX to hand gels and detox tunnels....
...One scoop to start: Andre De Cort, an associate of sanctioned oligarch Roman Abramovich who previously worked as his lawyer, has resigned as a director of Truphone....
...But it wasn’t until mid-March that some of the biggest pharma groups announced their intention to pursue a vaccine....
...“Before we pat the drug industry on the back too much, one has to recognise it got involved in this partly because the whole thing has been de-risked by government,” he says....
...I do not think that we're going to see the entire pharma industry switch to focusing on vaccines....
...“It’s the biggest vaccine programme in history and the logistics are enormous,” said Dr Nigel Watson, chief executive of the Wessex Local Medical Committees....
...The drugmaker said on Wednesday that it was waiving all benefits of the status — which include significant tax incentives and control over prices for at least seven years in a de facto monopoly....
...Gilead Sciences has come under fire for securing a de facto monopoly in the US for an experimental drug seen as a potential coronavirus treatment, with activists accusing the US drugmaker of “morbid calculus...
...The backdrop for European venture capital funding had “improved and shifted” in recent years, said Medicxi’s co-founder Francesco De Rubertis....
...Onno van de Stolpe, Galapagos chief executive, said he wanted to create a “European powerhouse”, not sell out to a large pharmaceutical company....
...The Swiss drugmaker’s exposure was reflected in a 2 per cent fall in European pharma sales last year....
...Bill de Blasio, New York mayor, is suing drug companies over the opioid crisis: "It's time for Big Pharma to pay for what they've done"....
...Mr Rose joins from Edmond de Rothschild, the private bank and investment group....
...Martijn De Vree and Frank Cooke join from Insight Investment and Mercer, the investment consultancy, respectively....
...The president took to Twitter to slam the US pharmaceutical group’s CEO saying: “Now that Ken Frazier of Merck Pharma has resigned from President’s Manufacturing Council, he will have more time to LOWER...
...Enter text in the de-jargoniser to assess its readability....
...It is still early days for big pharma’s digital push....
...MAAKIE DE BIEGeneral counsel Royal Mail Group Ms de Bie joined Royal Mail after its privatisation in 2013 and was given the task of helping to change the way the legal team operates....
...Pfizer de-branded Epanutin and handed over the distribution of the pills in generic form to Flynn....
...Roz De la Hay, formerly head of children’s marketing at Bloomsbury, saw Rowling’s development at close quarters. “Jo’s evolved organically. She had a very clear vision of how things should work....
...Alex De Groote, an analyst at Peel Hunt, said it was “hard to imagine any other plausible counter bidder”, given Fox’s 39 per cent stake....
...(Bloomberg) Decoding the UK A new collaboration between Biobank, the UK public sector research facility, and pharma companies GSK and Regeneron will decode the DNA of half a million Britons....
...In practice, pharma groups go for much longer without competition....
International Edition